Elizabeth Blackwell Institute for Health Research

Medicine & Life Sciences

1. Child 100%
2. Randomized Controlled Trials 84%
3. Systematic Reviews 83%
4. Random Allocation 83%
5. Cohort Studies 83%
6. Meta-Analysis 73%
7. Population 68%
8. England 65%
9. Longitudinal Studies 64%
10. Parents 63%
11. Alzheimer Disease 61%
12. Depression 60%
13. Therapeutics 54%
14. Primary Health Care 53%
15. Genes 53%
16. Neurons 51%
17. Parturition 51%
18. Memory 50%
19. Genome-Wide Association Study 49%
20. Brain 48%
21. Health 48%
22. Proteins 48%
23. Smoking 47%
24. Confidence Intervals 45%
25. Mothers 44%
26. Mendelian Randomization Analysis 42%
27. Cost-Benefit Analysis 42%
28. Prostatic Neoplasms 42%
29. Suicide 41%
30. HIV 40%
31. Pharmaceutical Preparations 40%
32. Infection 38%
33. Alcohols 37%
34. DNA Methylation 37%
35. Body Mass Index 37%
36. Single Nucleotide Polymorphism 36%
37. Odds Ratio 36%
38. Phenotype 35%
39. Genome 35%
40. Neoplasms 34%
41. Mortality 33%
42. Schizophrenia 32%
43. Anxiety 32%
44. Prospective Studies 31%
45. Parkinson Disease 31%
46. Pregnancy 30%
47. Genotype 30%
48. Short-Term Memory 30%
49. Costs and Cost Analysis 30%
50. Recognition (Psychology) 29%
51. Learning 28%
52. Observational Studies 27%
53. Obesity 26%
54. Interviews 26%
55. Uveitis 25%
56. Blood Pressure 25%
57. AMPA Receptors 24%
58. Exercise 24%
59. Hippocampus 24%
60. Anti-Bacterial Agents 24%
61. Chronic Fatigue Syndrome 23%
62. Animals 23%
63. Biomarkers 23%
64. Glucocorticoids 23%
65. Referral and Consultation 23%
66. Alcohol Drinking 23%
67. Neuronal Plasticity 23%
68. Hepacivirus 23%
69. Cognition 22%
70. Delivery of Health Care 22%
71. Food 22%
72. Outcome Assessment (Health Care) 22%
73. Inflammation 22%
74. Cross-Sectional Studies 22%
75. Mental Health 21%
76. Cues 21%
77. T-Lymphocytes 21%
78. Growth 21%
79. Wounds and Injuries 21%
80. Quality of Life 21%
81. Incidence 21%
82. Patient Reported Outcome Measures 21%
83. Synapses 20%
84. Psychology 20%
85. Aptitude 20%
86. Cats 20%
87. Education 20%
88. Epigenomics 20%
89. Psychotic Disorders 20%
90. N-Methyl-D-Aspartate Receptors 20%
91. Clinical Trials 20%
92. Mutation 20%